Innospec Inc (IOSP)

$130.22

+2.12

(+1.65%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $128.94
    $131.13
    $130.22
    downward going graph

    0.98%

    Downside

    Day's Volatility :1.67%

    Upside

    0.69%

    downward going graph
  • $93.34
    $132.37
    $130.22
    downward going graph

    28.32%

    Downside

    52 Weeks Volatility :29.49%

    Upside

    1.62%

    downward going graph

Returns

PeriodInnospec IncSector (Materials)Index (Russel 2000)
3 Months
5.76%
0.4%
0.0%
6 Months
8.11%
8.9%
0.0%
1 Year
18.18%
5.4%
0.0%
3 Years
47.75%
9.0%
-20.2%

Highlights

Market Capitalization
3.2B
Book Value
$47.47
Dividend Share
1.41
Dividend Yield
1.19%
Earnings Per Share (EPS)
5.88
PE Ratio
21.78
PEG Ratio
-2.95
Wall Street Target Price
141.5
Profit Margin
7.6%
Operating Margin TTM
10.58%
Return On Assets TTM
6.95%
Return On Equity TTM
13.0%
Revenue TTM
1.9B
Revenue Per Share TTM
77.97
Quarterly Revenue Growth YOY
-1.7999999999999998%
Gross Profit TTM
586.7M
EBITDA
226.7M
Diluted Eps TTM
5.88
Quarterly Earnings Growth YOY
0.24
EPS Estimate Current Year
6.66
EPS Estimate Next Year
7.61
EPS Estimate Current Quarter
1.64
EPS Estimate Next Quarter
1.62

Analyst Recommendation

Buy
    77%Buy
    22%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Innospec Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 8.66%

Current $130.22
Target $141.50

Company Financials

FY18Y/Y Change
Revenue
1.5B
↑ 13.02%
Net Income
85.0M
↑ 37.54%
Net Profit Margin
5.76%
↑ 1.03%
FY19Y/Y Change
Revenue
1.5B
↑ 2.46%
Net Income
112.2M
↑ 32.0%
Net Profit Margin
7.41%
↑ 1.65%
FY20Y/Y Change
Revenue
1.2B
↓ 21.16%
Net Income
28.7M
↓ 74.42%
Net Profit Margin
2.41%
↓ 5.0%
FY21Y/Y Change
Revenue
1.5B
↑ 24.33%
Net Income
93.1M
↑ 224.39%
Net Profit Margin
6.28%
↑ 3.87%
FY22Y/Y Change
Revenue
2.0B
↑ 32.38%
Net Income
133.0M
↑ 42.86%
Net Profit Margin
6.77%
↑ 0.49%
FY23Y/Y Change
Revenue
1.9B
↓ 0.76%
Net Income
139.1M
↑ 4.59%
Net Profit Margin
7.14%
↑ 0.37%
Q4 FY22Q/Q Change
Revenue
510.7M
↓ 0.45%
Net Income
25.5M
↓ 34.11%
Net Profit Margin
4.99%
↓ 2.55%
Q1 FY23Q/Q Change
Revenue
509.6M
↓ 0.22%
Net Income
33.2M
↑ 30.2%
Net Profit Margin
6.51%
↑ 1.52%
Q2 FY23Q/Q Change
Revenue
480.4M
↓ 5.73%
Net Income
28.9M
↓ 12.95%
Net Profit Margin
6.02%
↓ 0.49%
Q3 FY23Q/Q Change
Revenue
464.1M
↓ 3.39%
Net Income
39.2M
↑ 35.64%
Net Profit Margin
8.45%
↑ 2.43%
Q4 FY23Q/Q Change
Revenue
494.7M
↑ 6.59%
Net Income
37.8M
↓ 3.57%
Net Profit Margin
7.64%
↓ 0.81%
Q1 FY24Q/Q Change
Revenue
500.2M
↑ 1.11%
Net Income
41.4M
↑ 9.52%
Net Profit Margin
8.28%
↑ 0.64%
FY18Y/Y Change
Total Assets
1.5B
↑ 4.48%
Total Liabilities
647.9M
↑ 5.2%
FY19Y/Y Change
Total Assets
1.5B
↓ 0.31%
Total Liabilities
549.9M
↓ 15.13%
FY20Y/Y Change
Total Assets
1.4B
↓ 4.86%
Total Liabilities
452.5M
↓ 17.71%
FY21Y/Y Change
Total Assets
1.6B
↑ 12.42%
Total Liabilities
537.9M
↑ 18.87%
FY22Y/Y Change
Total Assets
1.6B
↑ 2.09%
Total Liabilities
563.3M
↑ 4.72%
FY23Y/Y Change
Total Assets
1.7B
↑ 6.47%
Total Liabilities
557.8M
↓ 0.98%
Q4 FY22Q/Q Change
Total Assets
1.6B
↓ 3.92%
Total Liabilities
563.3M
↓ 2.43%
Q1 FY23Q/Q Change
Total Assets
1.6B
↑ 1.27%
Total Liabilities
543.5M
↓ 3.52%
Q2 FY23Q/Q Change
Total Assets
1.6B
↓ 0.82%
Total Liabilities
516.0M
↓ 5.06%
Q3 FY23Q/Q Change
Total Assets
1.6B
↑ 0.48%
Total Liabilities
490.5M
↓ 4.94%
Q4 FY23Q/Q Change
Total Assets
1.7B
↑ 5.49%
Total Liabilities
557.8M
↑ 13.72%
Q1 FY24Q/Q Change
Total Assets
1.7B
↑ 1.49%
Total Liabilities
546.6M
↓ 2.01%
FY18Y/Y Change
Operating Cash Flow
104.9M
↑ 26.84%
Investing Cash Flow
-35.5M
↑ 19.93%
Financing Cash Flow
-36.2M
↓ 45.48%
FY19Y/Y Change
Operating Cash Flow
161.6M
↑ 54.05%
Investing Cash Flow
-31.0M
↓ 12.68%
Financing Cash Flow
-177.9M
↑ 391.44%
FY20Y/Y Change
Operating Cash Flow
145.9M
↓ 9.72%
Investing Cash Flow
-29.7M
↓ 4.19%
Financing Cash Flow
-86.8M
↓ 51.21%
FY21Y/Y Change
Operating Cash Flow
93.2M
↓ 36.12%
Investing Cash Flow
-36.2M
↑ 21.89%
Financing Cash Flow
-20.0M
↓ 76.96%
FY22Y/Y Change
Operating Cash Flow
81.7M
↓ 12.34%
Investing Cash Flow
-42.1M
↑ 16.3%
Financing Cash Flow
-33.7M
↑ 68.5%
Q4 FY22Q/Q Change
Operating Cash Flow
78.4M
↑ 96.98%
Investing Cash Flow
-15.1M
↑ 57.29%
Financing Cash Flow
-17.0M
↑ 4150.0%
Q1 FY23Q/Q Change
Operating Cash Flow
21.8M
↓ 72.19%
Investing Cash Flow
-22.0M
↑ 45.7%
Financing Cash Flow
400.0K
↓ 102.35%
Q2 FY23Q/Q Change
Operating Cash Flow
55.0M
↑ 152.29%
Investing Cash Flow
-17.3M
↓ 21.36%
Financing Cash Flow
-19.2M
↓ 4900.0%

Technicals Summary

Sell

Neutral

Buy

Innospec Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Innospec Inc
Innospec Inc
3.72%
8.11%
18.18%
47.75%
36.49%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
-1.92%
-1.24%
-14.64%
-10.54%
12.18%
Linde Plc
Linde Plc
1.05%
9.65%
14.12%
48.43%
120.46%
Dupont De Nemours Inc
Dupont De Nemours Inc
-1.25%
22.21%
3.13%
5.87%
7.95%
Sherwin-williams Company, The
Sherwin-williams Company, The
15.46%
13.55%
22.01%
20.06%
100.71%
Ecolab Inc.
Ecolab Inc.
1.25%
22.76%
28.95%
11.19%
22.06%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Innospec Inc
Innospec Inc
21.78
21.78
-2.95
6.66
0.13
0.07
0.01
47.47
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
23.39
23.39
1.37
12.23
0.16
0.05
0.03
67.08
Linde Plc
Linde Plc
34.48
34.48
2.65
15.49
0.16
0.07
0.01
80.78
Dupont De Nemours Inc
Dupont De Nemours Inc
86.51
86.51
1.64
3.63
0.02
0.03
0.02
56.41
Sherwin-williams Company, The
Sherwin-williams Company, The
33.78
33.78
4.16
11.45
0.68
0.1
0.01
14.95
Ecolab Inc.
Ecolab Inc.
45.45
45.45
2.33
6.57
0.2
0.07
0.01
23.46
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Innospec Inc
Innospec Inc
Buy
$3.2B
36.49%
21.78
7.6%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
Buy
$57.5B
12.18%
23.39
20.32%
Linde Plc
Linde Plc
Buy
$213.3B
120.46%
34.48
19.26%
Dupont De Nemours Inc
Dupont De Nemours Inc
Buy
$33.3B
7.95%
86.51
2.96%
Sherwin-williams Company, The
Sherwin-williams Company, The
Buy
$83.8B
100.71%
33.78
10.92%
Ecolab Inc.
Ecolab Inc.
Hold
$70.1B
22.06%
45.45
10.01%

Insights on Innospec Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 464.1M → 500.2M (in $), with an average increase of 3.6% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 37.8M → 41.4M (in $), with an average increase of 8.7% per quarter

  • Vs ECL

    In the last 1 year, Ecolab Inc. has given 28.9% return, outperforming this stock by 10.7%

Institutional Holdings

  • BlackRock Inc

    15.75%

  • Vanguard Group Inc

    12.49%

  • Allspring Global Investments Holdings, LLC

    9.30%

  • Wasatch Advisors LP

    7.91%

  • Dimensional Fund Advisors, Inc.

    4.81%

  • Victory Capital Management Inc.

    3.92%

Corporate Announcements

  • Innospec Inc Dividends September,2024

    In the quarter ending September,2024. Innospec Inc has declared dividend of $0.72

    Read More

Company Information

innospec is a global specialty chemicals company focused on bringing innovative new technologies to market combined with a fast and responsive service. we serve a range of industries across the world, bringing our products to customers in markets from oilfields, fuels, refineries and power stations to personal care. our global team of approximately 1300 employees spans 20 countries, applying their extensive experience and market understanding to customers’ local needs. integrating our global footprint with local service capability enables us to supply quality products that meet and anticipate changing market dynamics.

Organization
Innospec Inc
Employees
2400
CEO
Mr. Patrick S. Williams
Industry
Chemicals: Specialty

Discover More

FAQs